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Abstract Recent data from multiple laboratories indicate that
upon infection, many di¡erent families of viruses hijack the
dynein motor machinery and become transported in a retrograde
manner towards the cell nucleus. In certain cases, one of the
dynein light chains, LC8, is involved in this interaction. Using a
library of overlapping dodecapeptides synthesized on a cellulose
membrane (pepscan technique) we have analyzed the interaction
of the dynein light chain LC8 with 17 polypeptides of viral
origin. We demonstrate the strong binding of two herpesvirus
polypeptides, the human adenovirus protease, vaccinia virus
polymerase, human papillomavirus E4 protein, yam mosaic virus
polyprotein, human respiratory syncytial virus attachment gly-
coprotein, human coxsackievirus capsid protein and the product
of the AMV179 gene of an insect poxvirus to LC8. Our data
corroborate the manipulation of the dynein macromolecular
complex of the cell during viral infection and point towards
the light chain LC8 as one of the most frequently used targets
of virus manipulation.
1 2003 Published by Elsevier Science B.V. on behalf of the
Federation of European Biochemical Societies.
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1. Introduction
Dyneins are large protein complexes that function as micro-
tubule-based molecular motors generating force towards the
minus end of microtubules, with the intermediate and light
chains presumably involved in the dynein attachment to the
appropriate cargo [1]. Among the dynein light chains, we have
focused our work on the interaction of LC8, an 89-residue
protein, with its target sequences. This 8-kDa subunit (LC8
actual mass 10 kDa) was ¢rst identi¢ed as an integral compo-
nent of the Chlamydomonas reinhardtii outer dynein arm, in
association with the dynein intermediate chains at the base of
the soluble particle [2]. After the initial cloning and identi¢-
cation of LC8 as a neuronal nitric oxide synthase-interacting
protein [3], several other polypeptides were reported to bind
to this dynein light chain. The list include the proapoptotic
member of the Bcl-2 family Bim [4], the product of the Dro-
sophila swallow gene [5], a guanylate kinase domain-associ-
ated protein [6], DNA cytosine methyl transferase [7], the
transcription factor Kid-1 [7], a microtubule-associated pro-
tein [7], dynein heavy chain [7], BS69 [8], the potential onco-
gene AIBC1 [8], the Chlamydomonas radial spoke protein 3 [9]
as well as multiple proteins of unknown function [8].
Two di¡erent protein motifs can be recognized by LC8 in
its target proteins: a (K/R)XTQT and a G(I/V)QVD motif
[7,8]. Studies using multidimensional nuclear magnetic reso-
nance spectroscopy have revealed that the Gln (Q) present in
both motifs occupies an invariant position in the binding cleft
of LC8, establishing strong hydrogen bonds with the side
chains of Glu35 as well as Lys36 [10]. In both cases, the pep-
tides from the target sequences engage with the LC8 dimer as
a novel L-strand that elongates the preformed L-sheet [10,11].
Proteins that interact with LC8 through unknown mecha-
nisms include myosin V [6] and IUBK [12]. Over 20 cellular
proteins are currently known to interact with LC8, many of
them becoming subsequently transported along microtubules
in a retrograde manner. In most cases these target proteins
possess one of the two LC8 binding motifs mentioned above.
It is becoming more and more apparent that multiple vi-
ruses are able to sequester the dynein machinery of the in-
fected cell in order to move along the microtubules and gain
access to the cell nucleus [13^15]. In the case of both rabies
virus and Mokola virus (lyssavirus), the yeast two-hybrid
technology has revealed a direct interaction between the
KSTQT motif present in the viral P protein and LC8
[16,17]. Likewise, African swine fever virus (Asfarviridae)
has been reported to interact with LC8 through the TASQT
motif present in the viral polypeptide p54 [18]. We have syn-
thesized overlapping dodecapeptides covering the sequences of
viral proteins corresponding to papillomavirus, retrovirus
(HIV and EIAV), togavirus, poxvirus (entomopoxvirus, vac-
cinia and variola virus), potyvirus (yam mosaic potyvirus),
paramyxovirus (respiratory syncytial virus), adenovirus, her-
pesvirus, rotavirus, and coxsackievirus. Positive interactions
between LC8 and several viral proteins have been observed,
reinforcing the idea that the utilization of the dynein motor
could be a broad strategy adopted by a wide variety of viruses
of unrelated families.
2. Materials and methods
2.1. Peptide synthesis
Overlapping dodecapeptides for mapping studies were prepared by
automated spot synthesis (Abimed, Langenfeld, Germany) onto an
amino-derivatized cellulose membrane, immobilized by their C-termi-
0014-5793 / 03 / $22.00 J 2003 Published by Elsevier Science B.V. on behalf of the Federation of European Biochemical Societies.
doi:10.1016/S0014-5793(03)00516-7
*Corresponding author. Fax: (34)-91-394 4159.
E-mail address: nacho@bbm1.ucm.es (I. Rodr|¤guez-Crespo).
FEBS 27319 22-5-03
FEBS 27319FEBS Letters 544 (2003) 262^267
ni via a polyethylene glycol spacer, and N-terminally acetylated. We
used a sequential displacement of two amino acids during the syn-
thesis, which leads to an overlap of 10 residues between each two
consecutive dodecapeptides, an 8-residue overlap among three consec-
utive dodecapeptides, a 6-residue overlap among four consecutive
dodecapeptides, and so on [7].
2.2. Recombinant LC8 binding assays on cellulose-bound peptides
Puri¢cation of recombinant LC8 has been described previously [19].
The cellulose membranes were coated with 1% non-fat dried milk in
TBS (50 mM Tris, pH 7.0, 137 mM NaCl, 2.7 mM KCl) for 4 h at
room temperature. Incubation with the recombinant LC8 (0.13 WM)
was done overnight at room temperature [7]. Subsequently, the mem-
brane was incubated for 2 h at room temperature with a commercial
antibody against the hexahistidine tag present in the recombinant
protein (1:100 000 dilution in TBS). Development of the membrane
was performed by ECL following the manufacturer’s instructions. The
quanti¢cation of the intensity of each spot was performed utilizing a
UVI-tec digital image analyzer (UVItec, Cambridge, UK) and the
software UVIband V97. In every case, spots corresponding to the
dodecapeptides of the various proteins synthesized onto the same
membrane were compared with each other. Controls performed with
the antibody in the absence of recombinant LC8 were performed in
every case, in order to subtract the non-speci¢c binding due to the
reactivity of the antibody against certain synthetic dodecapeptides.
3. Results
Considering the existence of consensus LC8 binding motifs
in certain viral polypeptides that might result in a retrograde
transport along microtubules, we performed a homology
search within viral sequence databases. When putative LC8
binding motifs or homologous sequences were found, we syn-
thesized large portions of the selected viral protein as over-
lapping dodecapeptides on a cellulose membrane that was
subsequently incubated with recombinant LC8. We focused
initially on herpes- and adenovirus, since these two virus fam-
ilies are known to interact with the dynein motor.
3.1. Binding of LC8 to herpesvirus proteins
Two putative LC8-interacting proteins were selected: the
herpes simplex virus type 1 helicase (product of the UL9
gene) as well as the product of the human herpesvirus 6B
U19 gene. The human helicase possesses a KSTQT motif
whereas the product of the U19 gene possesses two contigu-
ous RSTQT motifs (see arrows in Fig. 1). This KSTQT motif
is also found in several LC8-interacting proteins, such as Bim
or Kid-1 [7,8], whereas the RSTQT motif includes a conser-
vative R substitution. One hundred and sixty amino acids of
each protein were synthesized as overlapping dodecapeptides
that were subsequently screened using the pepscan technique.
When recombinant LC8 was incubated with 75 overlapping
synthetic dodecapeptides of each protein, we could observe a
positive interaction in both cases (Fig. 1).
3.2. Binding of LC8 to adenovirus protease and to BS69
After a search for putative LC8-interacting domains, we
tested the binding of recombinant LC8 to the human adeno-
virus protease as well as to BS69, a cellular protein with trans-
activating properties that binds tightly to adenovirus E1A
using the pepscan technique (Fig. 2). A weak but reproducible
binding was observed in a KSTQT motif present in the ad-
enoviral protease, as well as a strong binding to VSTQT and
HRSTQT motifs present in BS69. The lower signal observed
in the case of the KSTQT motif present in the adenovirus
protease could be due to the two Val residues that £ank the
Fig. 1. Binding of LC8 to herpesvirus helicase and to the product of the U19 gene. Recombinant LC8 was incubated with a cellulose mem-
brane bearing 75 spots with synthetic dodecapeptides that cover 160 amino acids of each protein. Twenty-¢ve dodecapeptides were synthesized
on each line. The membrane was developed by ECL after incubation with a peroxidase-labeled anti-hexahistidine tag antibody. The arrows
mark the protein sequences that interact with LC8 (KSTQT in the helicase and RSTQT in the product of the U19 gene).
FEBS 27319 22-5-03
M. Mart|¤nez-Moreno et al./FEBS Letters 544 (2003) 262^267 263
LC8 consensus binding motif [7]. Hence, it is likely that the
three-dimensional fold adopted by the full-length protease in
solution promotes its interaction with LC8.
3.3. Binding of LC8 to other viral targets
Even if a viral polypeptide possesses a consensus LC8 bind-
ing motif such as KSTQT or GIQVD, it is important to in-
spect the neighboring residues, since they determine if the
interaction will eventually take place. On the other hand,
some variability can still be observed at the recognition se-
quences [7,8]. Hence, we synthesized dodecapeptides covering
14 viral proteins that resembled the consensus LC8 binding
Fig. 2. Binding of LC8 to adenovirus protease and to the human adenovirus-associated BS69 protein. Recombinant LC8 was incubated with a
cellulose membrane bearing 75 spots with synthetic dodecapeptides that cover 160 amino acids of each protein. Twenty-¢ve dodecapeptides
were synthesized on each line. The membrane was developed by ECL after incubation with a peroxidase-labeled anti-hexahistidine tag antibody.
The arrows mark the protein sequences that interact with LC8 (KSTQT in the protease and VSTQT and RSTQT in the BS69 protein.
Table 1
Analyzed protein sequences that failed to bind to LC8
Variola virus CR6 protein (7514341)
WAYLSKKDTGIEFVDNDRQDIYTLFQHTGRIVHSNLTETFRDYIFPGDKTSYWVWLNESI
Variola virus DR4 (9627525)
WKKRIAGRDYMTNLSRDTGIQQSNLTETIRNCQKNRNIYGLYIHYNLVINVVIDWITDVI
Amsacta moorei entomopoxvirus spheroidin (9964501)
RYGEFEVYNADTGLIYAKNLSIKNYDTVIQVERLPVNLKVRAYTKDENGRNLCLMKITSS
HIV matrix protein (7715890)
LERFAINPGLLETSEGCQQIIEQLQSTLKTGSEELKSLFNTVATLWCVHQRIEVKDTREA
EIAV core protein (13383732)
MVSIAFYGGIPGGISTPITQQTKSTDTQKGDHMVYQPYCYNDSHKAEMAEARDTRYQEEM
Rubella virus C structural protein (16923735)
RRRGNRGRGQRRDWSRAPPPPEERQESRSQTPAPKPSRAPPQQPQPPRMQTGRGGSAPRP
Human poliovirus 1 VP2 protein (1335516)
SPNIEACGYSDRVLQLTLGNSTITTQEAANSVVAYGRWPEYLRDSEANPVDQPTEPDVAA
Rotavirus VP4 protein (1519243)
LKEMATQTDGMNFDDISAAVLKTKIDKSTQLNTNTLPEIVTEASEKFIPNRAYRVIKDDE
The accession numbers are shown in parentheses and the sequence motifs initially suspected to bind to LC8 are underlined. In several cases
larger stretches of sequence were analyzed, although only 60 residues are shown for clarity.
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motifs and incubated them in the presence of recombinant
LC8. Special care was taken when searching for homology
within sequences present in polypeptides of virus known to
bind to dynein or to require intact microtubules for e¡ective
infection. Additionally, we also inspected several virus sequen-
ces that were recently proposed to bind to LC8 according to
homology studies [20]. In all cases, we screened a minimum of
60 residues (25 spots) and a maximum of 110 residues (50
spots).
A very strong interaction was observed in the case of hu-
man papillomavirus E4 protein, Amsacta moorei entomopox-
virus, vaccinia virus polymerase, yam mosaic virus polypro-
tein, human syncytial virus attachment glycoprotein and
human coxsackievirus A3 capsid protein (Fig. 3). In all cases,
LC8 binding was observed to sequences that include a Gln
residue (Q). In ¢ve out of the six viral sequences that inter-
acted with LC8, the Gln residue was followed by a Thr res-
idue. Conversely, eight other viral sequences failed to interact
with LC8, despite their sequence similarity with the LC8 bind-
ing sequences present in target proteins (Table 1).
4. Discussion
The absolute requirement of intact microtubules for e⁄-
cient herpesvirus infection as well as the interaction of the
virus with the dynein machinery is well established (see [21]
and references therein). In epithelial cells and in axons, incom-
ing cytosolic capsids are transported along microtubules to-
wards the nucleus [22,23]. In fact, the herpes simplex virus
UL34 protein has been reported to interact with the neuronal
isoform of the intermediate chain of cytoplasmic dynein [24],
although this polypeptide is not present in secreted virions.
Remarkably, one of the polypeptides that interacted with LC8
(Fig. 1) was the product of the herpes simplex 1 UL9 gene, a
protein with helicase and DNA binding activities [25]. It re-
mains to be established if, after viral uncoating, the retrograde
transport of the helicase towards the nucleus is indispensable
for the viral life cycle. Additionally, a very strong interaction
was observed between LC8 and the product of the human
herpesvirus U19 gene, a protein of 325 amino acids of un-
known function (not to be confused with the product of the
UL19 (VP5) gene of HSV-1, the major capsid protein) [26].
Two contiguous binding sites were observed in these polypep-
tides, both of them displaying consensus LC8 recognition se-
quences (Fig. 1).
As in the case of herpesvirus, numerous reports have de-
scribed the microtubule-dependent retrograde transport of ad-
enovirus during infection [23,27^29]. In fact, injection of func-
tion-blocking antibodies against cytoplasmic dynein, but not
kinesin, blocked nuclear localization of adenoviruses, consis-
tent with a minus-end-directed motility [29]. Using the pep-
scan technique, we could also identify an interaction between
human adenovirus protease and recombinant LC8 (Fig. 2).
Although the consensus KSTQT is present in the adenoviral
protease, the two £anking Val residues probably contribute to
the reduction of the binding a⁄nity, as previously shown
when this motif was inserted in a poly-Val dodecapeptide
[7]. Con¢rmation of this interaction would be tentatively ob-
tained with co-immunoprecipitation or co-immuno£uores-
cence studies using anti-protease antibodies. In addition, we
also screened human adenovirus E1A-associated BS69 protein
for LC8-interacting sequences. Using LC8 as bait in a yeast
two-hybrid experiment, this cellular protein was equally ¢shed
using a rat cDNA library [8]. BS69 is a transcriptional co-
repressor protein and a potential tumor suppressor that binds
to the adenoviral oncoprotein E1A [30]. Incubation of re-
combinant LC8 with BS69 dodecapeptides results in two pos-
itive interactions: a weak binding to VSTQT and a very
strong binding to the RSTQT motif (Fig. 2). As previously
mentioned, adenovirus type 2 E3 14.7-kDa protein also inter-
acts with the dynein light chain TCTEL1 using a small
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3. Binding of LC8 to additional viral targets. Recombinant
LC8 was incubated with a cellulose membrane bearing spots with
synthetic dodecapeptides that cover sequences corresponding to six
di¡erent viral proteins. For clarity, only 25 dodecapeptides (60 ami-
no acids) are shown on each line. The membrane was developed by
ECL after incubation with a peroxidase-labeled anti-hexahistidine
tag antibody. The arrows and boxes mark the protein sequences
that interact with LC8 together with the dodecapeptide that showed
the strongest binding to LC8. Accession numbers are shown in pa-
rentheses.
Table 2
Summary of viral sequences that interact with the dynein light chain
LC8
Rabies virus P protein KSTQT
Mokola virus P protein KSTQT
African swine fever virus p54 TASQT
Human herpes simplex helicase KSTQT
Human herpesvirus U19 gene RSTQT
Human adenovirus protease KSTQT
Human papillomavirus E4 protein KQTQT
A. moorei entomopoxvirus AMV179 ORF KSTQT
Vaccinia virus polymerase KQTQT
Yam mosaic potyvirus polyprotein RSTQT
RSV attachment glycoprotein TSTQT
Human coxsackievirus capsid protein RVMQL
The interaction between the ¢rst three proteins and LC8 has been
reported in [7,16^18].
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GTPase as a bridge protein [28]. Thus, it is likely that the full
picture of adenovirus^dynein interactions might involve addi-
tional proteins not yet identi¢ed.
Six additional polypeptides interact with LC8 according to
our pepscan analysis, many of them belonging to viruses
known to associate with microtubules (Fig. 3). We observed
that papillomavirus E4 protein uses a KQTQT motif in order
to interact with LC8, in agreement with previous observations
reporting that nocodazole treatment of infected cells does not
completely impair internalization of bovine papillomavirus
but retains the incoming virions in cytoplasmic vesicles, hence
abrogating their transport towards the nucleus [31]. Our ¢nd-
ing that vaccinia virus polymerase interacts (albeit weakly)
with LC8 through a KQTQT motif is also noteworthy. The
requirement of dynein integrity for vaccinia virus infection has
been demonstrated through di¡erent approaches. Disruption
of the microtubular network of infected cells with nocodazole
altered the localization of vaccinia virus at the microtubule
organizing center (MTOC), and infected cells overexpressing
p50/dynamitin which acts as a dominant-negative for dynein^
dynactin function, abrogated the correct positioning of the
virus during infection [32]. Further experiments will be neces-
sary in order to shed light on the strong interaction that we
observed between the human RSV attachment glycoprotein
and LC8 (Fig. 3), since this protein is located in the extracel-
lular domain of the virus.
Despite the recently published interaction of retrovirus with
the dynein machinery [33], we have been unable to obtain
binding of LC8 to HIV matrix protein or to identify any
LC8 consensus binding sequence within the HIV genome. A
putative LC8 binding motif was nevertheless observed in the
core protein of the retrovirus EIAV (KSTDTQ), although
incubation with recombinant LC8 rendered no interaction
(Table 1). The most likely explanation to the reported dy-
nein-dependent retrograde transport of HIV might be that
one of the polypeptides present in this retrovirus must interact
either with dynactin, with another dynein light chain or inter-
mediate chain or via a bridging protein, as reported in the
case of adenovirus E3 protein.
It must be noted as well that rotavirus P4 protein and
poliovirus 1 VP2 protein, two of the polypeptides that Poisson
and coworkers proposed to bind to LC8 [20], failed to do so
according to our assay (Table 1). This observation suggests
that notwithstanding the plasticity of the binding cavity with-
in LC8 which is able to adapt to a considerable number of
peptide variants of the two consensus motifs, it is di⁄cult a
priori to predict a positive interaction. Additionally, the inter-
actions established between the residues present in the viral
polypeptides that £ank the consensus LC8 binding motifs
must be determinant for a successful interaction to take place.
Signi¢cantly, it has been shown that while the LC8 binding
motif in the P protein of rabies virus is important for binding
to LC8, it does not a¡ect neurotropism unless it is disrupted
in an already attenuated virus mutant [34]. In fact, LC8 co-
puri¢es with wild-type virions of rabies virus isolated in a
sucrose gradient, but not with virions containing phosphopro-
tein mutants with alterations in the KSTQT motif [34].
The approach that we describe in this work is complemen-
tary to the more common yeast two-hybrid screening. More-
over, with the pepscan technique we can inspect if a large
variety of viral sequences interact with LC8, whereas no viral
libraries containing multiple, unrelated, virus genes are com-
mercially available. The list of plant and animal viruses
known to associate with the microtubule cytoskeleton or di-
rectly with microtubules in vitro is signi¢cant [13^15]. Indeed,
there is a growing list of viruses, at least those requiring nu-
clear import for replication, that use dynein to approach the
perinuclear position of the MTOC. It is also widely recog-
nized that virus infection often resulted in disruption of the
cytoskeleton. Our results suggest that the genome of as many
as 12 viruses belonging to distant families have evolved intro-
ducing LC8 recognition sequences that might allow these vi-
ruses to associate with the dynein motor and become trans-
ported towards the minus end of microtubules after infection.
Interestingly, in all cases, modi¢cations of the KSTQT motif
rather than the GIQVDR motif are observed (Table 2). How-
ever, further experiments will be necessary in order to dem-
onstrate that the proteins described in this work that interact
with LC8 using the pepscan technique are able to recruit the
complete dynein motor in cells. In addition, since LC8 is also
a subunit of myosin V, the possibility exists that, at least in
certain cases, the interaction of LC8 with certain viral proteins
results in plus-end-directed microtubular transport. In sum-
mary, our data provide support for the indispensable role of
the macromolecular motor dynein in viral infection and iden-
tify novel protein^protein interactions endowed with physio-
logical relevance.
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